The percentage of GPC1+ EVs and the GPC1 protein expression in EVs from tumour tissues and plasma of CRC patients before surgical treatment was significantly elevated compared to that in the peritumoural tissues and the plasma of healthy controls. This evidence concerns the gene GPC1 and colorectal carcinoma.